Safety a problem for new generation drugs, too
October 21, 2008 By LINDSEY TANNER , AP Medical Writer(AP) -- Nearly a fourth of widely used new-generation biological drugs that treat several common diseases produce serious side effects that lead to safety warnings soon after they go on the market, the first major study of its kind found.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Anti-growth factor drugs raise hope and concern for treatment of children's eye diseases
Aug 03, 2009 |
not rated yet |
0
14 drugs identified as most urgently needing study for off-label use, Stanford professor says
Nov 24, 2008 |
5 / 5 (1) |
0
GAO: FDA yet to make safety changes post-Vioxx
Dec 09, 2009 |
not rated yet |
0
FDA weighs options to reduce painkiller overdoses
Jun 29, 2009 |
not rated yet |
0
New research to reduce drug side-effects
Jul 09, 2009 |
4 / 5 (1) |
0
